NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

genedrive plc (LSE: GDR)

 
GDR Technical Analysis
5
As on 20th Dec 2024 GDR STOCK Price closed @ 2.27 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.68 & Strong Sell for SHORT-TERM with Stoploss of 12.53 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GDRSTOCK Price

Open 2.10 Change Price %
High 2.43 1 Day 0.17 8.10
Low 2.07 1 Week 0.27 13.50
Close 2.27 1 Month -0.11 -4.62
Volume 19591520 1 Year -13.23 -85.35
52 Week High 16.00 | 52 Week Low 1.45
 
LSE UK Most Active Stocks
TRP 0.04 %
LLOY 54.20 -0.18%
DKE 0.15 0.00%
ORCP 0.02 -33.33%
NNN 0.09 50.00%
DMTR 0.03 0.00%
BOIL 0.08 0.00%
VOD 66.50 -0.84%
MCLS 1.68 46.09%
DIS 0.12 0.00%
 
LSE UK Top Gainers Stocks
0YY7 20.40 280.60%
SSIF 18.50 208.33%
CGW 55.03 107.66%
CNN 65.00 85.71%
VENC 139.60 65.21%
0UTC 0.41 51.85%
NNN 0.09 50.00%
NNN 0.09 50.00%
TIR 0.15 50.00%
MCLS 1.68 46.09%
 
LSE UK Top Losers Stocks
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
DNA 0.06 -99.90%
JPE 12.55 -98.66%
SPPC 0.15 -93.75%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
AGM 1.00 -80.95%
0L7R 0.29 -78.20%
 
 
GDR
Daily Charts
GDR
Intraday Charts
Whats New @
Bazaartrend
GDR
Free Analysis
 
GDR Important Levels Intraday
RESISTANCE2.96
RESISTANCE2.74
RESISTANCE2.60
RESISTANCE2.47
SUPPORT2.07
SUPPORT1.94
SUPPORT1.80
SUPPORT1.58
 
GDR Forecast December 2024
4th UP Forecast11.13
3rd UP Forecast8.29
2nd UP Forecast6.53
1st UP Forecast4.78
1st DOWN Forecast-0.24
2nd DOWN Forecast-1.99
3rd DOWN Forecast-3.75
4th DOWN Forecast-6.59
 
GDR Weekly Forecast
4th UP Forecast6.12
3rd UP Forecast4.89
2nd UP Forecast4.12
1st UP Forecast3.36
1st DOWN Forecast1.18
2nd DOWN Forecast0.42
3rd DOWN Forecast-0.35
4th DOWN Forecast-1.58
 
GDR Forecast2024
4th UP Forecast29.42
3rd UP Forecast20.71
2nd UP Forecast15.33
1st UP Forecast9.95
1st DOWN Forecast-5.41
2nd DOWN Forecast-10.79
3rd DOWN Forecast-16.17
4th DOWN Forecast-24.88
 
 
GDR Other Details
Segment EQ
Market Capital 20189598.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
GDR Address
GDR
 
GDR Latest News
 
Your Comments and Response on genedrive plc
 
GDR Business Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small molecular diagnostic platform, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom. Address: The CTF Building, Manchester, United Kingdom, M13 9XX
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service